HomeAI · summaries
Storia in 2 fonti
The Irish Times view on drug reimbursement: lessons from the Skyclarys saga
The process of negotiating drug reimbursements is opaque and drawn-out
Confronto fonti
2 prospettive sulla stessa storiaTimeline cronologica
- ·
irishtimes.com
Decision due on HSE funding for treatment for rare genetic disorder
The drug omaveloxolone, branded as Skyclarys, was approved in the US for the treatment of the disease, followed by Europe
- ·
HSE agrees to fund drug for patients with Friedreich’s ataxia
Omaveloxolone, branded as Skyclarys, has been approved in US and Europe for treatment of disease
